Methotrexate therapy is associated with depletion of all CD4+ T cell subsets, including Tregs, and also with the development of rheumatoid nodules following improvement of arthritis, as has been reported in previous studies [34–36]. This evidence concerns the gene CD4 and rheumatoid arthritis.